- Cameroun: au moins 79 élèves enlevés dans le nord-ouest
- Tunisie: une femme se fait exploser à Tunis
- Gabon: Anonymous s’en prend au gouvernement
- Cameroun: Paul Biya réélu
- Presidential election in Cameroon:
- Cameroun: élection présidentielle sous tension
- Burkina Faso: 3 personnes enlevées et 3 gendarmes tués
- How Djibouti like Zambia is about to loose its port to China
- L’Afrique présente au 3è forum de coopération entre la Chine et le continent
- Mali: IBK rempile pour un second mandat
Liberia gives experimental Ebola drug
Health care workers in Liberia have administered three doses of the rare, experimental drug ZMapp to three doctors suffering from Ebola, two medical workers in Monrovia.
Liberia, the West African country with the highest death toll from the tropical virus at 413, received three doses of the rare serum in a special consignment this week.
Doctors Zukunis Ireland and Abraham Borbor from Liberia and Dr. Aroh Cosmos Izchukwu from Nigeria are the first Africans to receive the treatment. The drug has already been administered to two American healthcare workers and a Spanish priest, all previously working in Liberian hospitals.
The U.S. healthcare workers’ health has since improved but the Spanish priest died.
The apparent improvement in the two U.S. healthcare workers’ condition has stoked popular pressure to make the drug available to Africans – a cause advocated by the Twitter hashtag group #giveustheserum.
There is currently no vaccine against the highly-contagious disease and other forms of treatment are only designed to relieve symptoms such as fever, vomiting and haemorrhaging.
Up to 90 percent of victims die – a fatality rate so high that the U.S. Centers for Disease Control and Prevention (CDC) classifies the illness as a category A “bioterrorism agent” – although the current outbreak fatality rate is near 60 percent.
2 Comments